Avricore Health Stock Fundamentals
| AVCRF Stock | USD 0.04 0 7.42% |
Avricore Health fundamentals help investors to digest information that contributes to Avricore Health's financial success or failures. It also enables traders to predict the movement of Avricore Pink Sheet. The fundamental analysis module provides a way to measure Avricore Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Avricore Health pink sheet.
Avricore |
Avricore Health Company Current Valuation Analysis
Avricore Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Avricore Health Current Valuation | 21.9 M |
Most of Avricore Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avricore Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Avricore Health has a Current Valuation of 21.9 M. This is 99.85% lower than that of the Healthcare sector and 99.72% lower than that of the Diagnostics & Research industry. The current valuation for all United States stocks is 99.87% higher than that of the company.
Avricore Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Avricore Health's current stock value. Our valuation model uses many indicators to compare Avricore Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Avricore Health competition to find correlations between indicators driving Avricore Health's intrinsic value. More Info.Avricore Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Avricore Health's earnings, one of the primary drivers of an investment's value.Avricore Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avricore Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Avricore Health could also be used in its relative valuation, which is a method of valuing Avricore Health by comparing valuation metrics of similar companies.Avricore Health is currently under evaluation in current valuation category among its peers.
Avricore Fundamentals
| Return On Equity | -0.38 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.95) % | |||
| Operating Margin | (1.23) % | |||
| Current Valuation | 21.9 M | |||
| Shares Outstanding | 98.62 M | |||
| Shares Owned By Insiders | 8.58 % | |||
| Price To Book | 14.51 X | |||
| Price To Sales | 28.37 X | |||
| Revenue | 122.81 K | |||
| Gross Profit | 30.52 K | |||
| EBITDA | (1.65 M) | |||
| Net Income | (1.71 M) | |||
| Cash And Equivalents | 1.44 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.02 % | |||
| Current Ratio | 13.64 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (1.23 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 13 | |||
| Beta | -2.1 | |||
| Market Capitalization | 25.64 M | |||
| Total Asset | 2.28 M | |||
| Net Asset | 2.28 M |
About Avricore Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avricore Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avricore Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avricore Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. Avricore Health is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Avricore Pink Sheet
Avricore Health financial ratios help investors to determine whether Avricore Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Avricore with respect to the benefits of owning Avricore Health security.